Table 2.
Grade 3, 4 or 5 Toxicities Possibly or Probably Related to Treatment During and After Course 1*
Course 1 | After Course 1 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dose Level | Dose Level | |||||||||||||||
Adverse Event† | 1 (n = 3) | 2 (n = 4) | 5 (n = 6) | 6 (n = 6) | 1 (n = 3) | 2 (n = 4) | 5 (n = 5) | 6 (n = 2) | ||||||||
Grade | Grade | Grade | Grade | Grade | Grade | Grade | Grade | |||||||||
3 | 3 | 4 | 3 | 4 | 3 | 4 | 3 | 4 | 3 | 4 | 5 | 3 | 4 | 3 | 4 | |
Elevated lipase | 1 | |||||||||||||||
Hypophosphatemia | 2 | 1 | ||||||||||||||
Hypokalemia | 1 | |||||||||||||||
Hyponatremia | 1 | |||||||||||||||
Anorexia | 1 | |||||||||||||||
Weight loss | 1 | |||||||||||||||
Vomiting | 1 | |||||||||||||||
Hand-foot syndrome | 1 | 1 | 1 | 1 | 2 | |||||||||||
Pneumothorax | 1 | |||||||||||||||
Decreased leukocytes (total) | 1 | 2 | 2 | 1 | 1 | |||||||||||
Lymphopenia | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | |||||
Neutropenia | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 1 | |||||
Anemia | 1 | 2 | 1 | |||||||||||||
Thrombocytopenia | 1 | |||||||||||||||
Thrombosis | 1 | |||||||||||||||
Febrile neutropenia | 1 | 1 | ||||||||||||||
Infection with neutropenia | 1 | |||||||||||||||
Bladder | 1 |
Grades are according to National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0.
Each adverse event was counted once (any course, highest grade) for each patient.